ABBV · AbbVie
Latest news, signals, and AI analysis for AbbVie (ABBV) on Catalayer. Updated continuously as stories are indexed across our news feed.
Recent ABBV News
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie: Shares Defy Sell-Side Downgrades, And That's Bullish (Technical Analysis)
Related Tickers
$JNJ · Johnson & Johnson$LLY · Eli Lilly$PFE · Pfizer$MRK · Merck$NVO · Novo Nordisk$GILD · Gilead SciencesFrequently Asked Questions
What sector does ABBV belong to?
ABBV (AbbVie) is classified under the Pharma sector on Catalayer. You can browse all news in this sector at /sector/pharma.
Where can I track real-time ABBV news?
Catalayer aggregates ABBV coverage from Reuters, Bloomberg, CNBC, MarketWatch, Yahoo Finance, Seeking Alpha, Barron’s, WSJ, Motley Fool, Benzinga, TipRanks and 20+ other sources. View the live feed at https://catalayer.com/stocks/ABBV.
How fast are ABBV news alerts on Catalayer?
News is polled every 30–60 seconds. ABBV-related stories appear in your workspace within minutes of publication, and you can create a custom monitor to get instant alerts.
Does Catalayer provide AI analysis for ABBV?
Yes. The Market Intelligence tier adds AI-powered event classification (monetary policy, earnings, guidance, M&A), directional impact (bullish/bearish), magnitude, and affected-sector analysis to every ABBV story.
Is ABBV covered in any Catalayer signal channels?
Signal channels and custom keyword monitors both support ABBV. Free accounts get 1 monitor; Plus ($29/mo) unlocks 5 monitors with boolean rules across tickers, sectors, and topics.